Novavax Inc (NASDAQ:NVAX)
| 7.33 Delayed Data As of 4:00pm ET |  +0.20 / +2.81%Today’s Change | 5.61 Today|||52-Week Range 25.66 | -28.70% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -156.9M | -280.0M | -183.8M | -184.7M | |
| Depreciation | 6.0M | 8.5M | 9.8M | 8.2M | ||
| Total Other Cash Flow | 14.9M | 23.5M | 26.2M | 12.9M | ||
| Funds From Operations | -136.1M | -248.0M | -147.8M | -163.7M | ||
| Funds From/For Other Operating Expenses | -46.2M | 10.8M | -11.2M | 21.1M | ||
| Net Cash Flow - Operating Activities | -89.9M | -258.8M | -136.6M | -184.8M | ||
| Investing | Increase In Investments | -228.5M | -356.6M | -218.0M | -120.2M | |
| Decrease In Investments | 225.5M | 402.8M | 258.2M | 150.1M | ||
| Capital Expenditures | -18.3M | -18.2M | -4.2M | -1.4M | ||
| Fixed Asset Disposal | 18.0K | 11.0K | 0.00 | -- | ||
| Net Cash Flow Investing | -21.3M | 28.0M | 36.0M | 28.6M | ||
| Financing | Short Term Borrowings | -- | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | 315.0M | 0.00 | 0.00 | ||
| Long Term Debt Reduction | -667.0K | -466.0K | -37.0K | 0.00 | ||
| Net Proceeds Stock Sale | 209.1M | 3.8M | 64.6M | 102.8M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | -- | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | -- | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | -- | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 126.0K | 39.3M | 0.00 | 0.00 | ||
| Net Cash Flow - Financing | 208.3M | 279.0M | 64.5M | 102.8M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -150.0K | -335.0K | 142.0K | -48.0K | |
| Net Change In Cash | 97.1M | 48.3M | -36.1M | -53.4M | ||
